Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Beta Drugs Ltd.
NSE: BETA
|
BSE: 531481
|
ISIN: INE351Y01019
|
Industry: Pharmaceuticals
|
Expensive Rocket
2090.5000
-65.20
(
-3.02
%)
NSE
Jul 03, 2026
15:31 PM
111.14% Gain from 52W Low
Volume:
36,025
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Beta Drugs Ltd.
08 Nov 2024
2090.50
-3.02%
Beta Drugs | H1FY25 Result Update
Buy:
Beta Drugs Ltd.
by
Edelweiss
Target: 2245
Target
Edelweiss
Strong show in H1; near-term growth factored in
Beta Drugs Ltd. is trading above all available SMAs
More from Beta Drugs Ltd.
Recommended
Five Interesting Stocks Today - July 3, 2026
The Baseline |
03 Jul 2026, 05:37PM
Market closes higher, led by IT and realty stocks
Trendlyne Marketwatch |
03 Jul 2026
Q1FY27: What's driving the strongest growth forecasts?
The Baseline |
02 Jul 2026